For instance, BCL7A and GRB10, which were found to be protective factors in certain cancers, are known to regulate immune-related pathways and cellular signaling, potentially enhancing anti-tumor immunity and suppressing oncogenic activity. This evidence concerns the gene BCL7A and neoplasm.